🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed as a Phase III, multicenter trial, comparing progres...
Status
Completed
Location
Yale University School of Medicine
Start Date
2005-12
Trial ID
NCT00329030
Treatments Being Tested
The purpose of the study is to assess the response rate of patients with re...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2007-01
Trial ID
NCT00490490
Treatments Being Tested
This is a single-arm, open-label, multicenter study of Iodine I-131 Anti B1...
Status
Completed
Location
Multiple Locations
Start Date
1998-07
Trial ID
NCT00996593
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 tositum...
Status
Completed
Location
Providence Cancer Center at Providence Hospital
Start Date
2009-04
Trial ID
NCT00770224
Treatments Being Tested
This study will further characterize the activity of Tositumomab and Iodine...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-04
Trial ID
NCT00240565
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 tositum...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2006-07
Trial ID
NCT00416312
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop cancer...
Status
Completed
Location
Alaska Regional Hospital Cancer Center
Start Date
2001-03
Trial ID
NCT00006721
Treatments Being Tested
A total of 506 patients, 253 per arm, will be enrolled at 30 to 40 sites in...
Status
Unknown
Location
Northside Hospital
Start Date
2004-04
Trial ID
NCT00078598
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 tositum...
Status
Completed
Location
Alaska Regional Hospital Cancer Center
Start Date
2005-11
Trial ID
NCT00107380
Mantle cell lymphoma (MCL) is a rare and aggressive type of lymphoma, with ...
Status
Completed
Location
Memorial Sloan Kettering at Basking Ridge
Start Date
2011-11-29
Trial ID
NCT01484093
Treatments Being Tested